期刊
AGING-US
卷 3, 期 12, 页码 1169-1177出版社
IMPACT JOURNALS LLC
DOI: 10.18632/aging.100408
关键词
oxytocin; visceral obesity; fatty liver; metabolic syndrome; impaired glucose tolerance; feeding; energy expenditure
资金
- Japan Society for the Promotion of Science (JSPS) [20790663, 18390065, 20390061, 23390044, 23115715]
- Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23126523]
- Ministry of Education, Culture, Sports, Science and Technology of Japan [10036069]
- Takeda Science Foundation
- Sumitomo Foundation
- KEIRIN RACE
- Grants-in-Aid for Scientific Research [20790663, 18390065, 23126523] Funding Source: KAKEN
Recent studies suggest that oxytocin (Oxt) is implicated in energy metabolism. We aimed to explore acute and sub-chronic effects of peripheral Oxt treatment via different routes on food intake and energy balance. Intraperitoneal (ip) injection of Oxt concentration-dependently decreased food intake in mice. Ip Oxt injection induced c-Fos expression in the hypothalamus and brain stem including arcuate nucleus (ARC), paraventricular nucleus (PVN) and nucleus tractus solitarius (NTS). Subcutaneous (sc) injection of Oxt suppressed food intake in normal and high fat diet-induced obese (DIO) mice. Daily sc injection of Oxt for 17 days in DIO mice reduced food intake for 6 days and body weight for the entire treatment period and additional 9 days after terminating Oxt. Oxt infusion by sc implanted osmotic minipumps for 13 days in DIO mice reduced food intake, body weight, and visceral fat mass and adipocyte size. Oxt infusion also decreased respiratory quotient specifically in light phase, ameliorated fatty liver and glucose intolerance, without affecting normal blood pressure in DIO mice. These results demonstrate that peripheral Oxt treatment reduces food intake and visceral fat mass, and ameliorates obesity, fatty liver and glucose intolerance. Peripheral Oxt treatment provides a new therapeutic avenue for treating obesity and hyperphagia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据